Appendix B: Panel Roster and Financial Disclosures
Toxoplasma gondii
| Member | Institution | Financial Disclosure | |
|---|---|---|---|
| Company | Relationship | ||
| Sarita Boyd | U.S. Food and Drug Administration | None | N/A |
| Joseph Kovacs* | National Institutes of Health | None | N/A |
| Janaki Kuruppu | National Institutes of Health | None | N/A |
| Leon Lai | MedStar Washington Hospital Center | None | N/A |
| Jose M. Miro | Hospital Clínic de Barcelona–IDIBAPS, University of Barcelona, Spain | None | N/A |
| Daniel Podzamczer | Fight AIDS and Infectious Disease Foundation, Hospital Germans Trias i Pujol, Badalona, Spain | Gilead Sciences | Consultant |
| MSD | |||
| Janssen | |||
| ViiV Healthcare | |||
| Bryan R. Smith | National Institutes of Health | None | N/A |
| * Section Group Lead Note: Members are required to update disclosures annually and to notify guideline staff of any relevant changes in status during the interim. | |||
Download Guidelines
- Section Only PDF (17.85 KB)
- Full Guideline PDF (6.02 MB)
- Tables Only PDF (1.18 MB)